$IMGN ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock

on December 2, 2021 News and Tags: , , , with 0 comments
Time:
12:00 AM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock

on December 1, 2021 News and Tags: , , , with 0 comments
Time:
12:00 AM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Announces Proposed Public Offering of Common Stock

on November 30, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Announces Positive Top-Line Results from Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer

on November 30, 2021 News and Tags: , , , with 0 comments
Time:
6:30 AM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

on November 24, 2021 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Appoints Tracey L. McCain, Esq. to Its Board of Directors

on November 17, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

on November 16, 2021 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Appoints Kristen Harrington-Smith as Senior Vice President and Chief Commercial Officer

on November 16, 2021 News and Tags: , , , with 0 comments
Time:
6:30 AM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

on November 1, 2021 News and Tags: , , , with 0 comments
Time:
8:03 PM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Reports Recent Progress and Third Quarter 2021 Financial Results

on October 29, 2021 News and Tags: , , , with 0 comments
Time:
6:30 AM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2021 Operating Results

on October 14, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

on October 1, 2021 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Appoints Helen M. Thackray, MD to its Board of Directors

on September 22, 2021 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual Healthcare Conference

on May 20, 2021 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Announces Mature Data from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with AvastinĀ® in Recurrent Ovarian Cancer, Regardless of Platinum Status

on May 19, 2021 News and Tags: , , , with 0 comments
Time:
5:00 PM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more

$IMGN ImmunoGen Reports Recent Progress and First Quarter 2021 Financial Results

on May 10, 2021 News and Tags: , , , with 0 comments
Time:
6:30 AM
Symbol:
IMGN
Source:
Business Wire News Releases
Read more